Page last updated: 2024-10-31

n-(6-aminohexyl)-1-naphthalenesulfonamide and Prostatic Neoplasms

n-(6-aminohexyl)-1-naphthalenesulfonamide has been researched along with Prostatic Neoplasms in 1 studies

N-(6-aminohexyl)-1-naphthalenesulfonamide: calmodulin antagonist; RN given refers to parent cpd

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
"Whereas the treatment of prostate cancer cells individually with anti-CaM drug or calcimycin, which increases intracellular Ca(++) and activates Cpn, led to minimal AR breakdown, combined treatment led to a precipitous decrease in AR protein levels."1.37Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. ( Bai, VU; Barrack, ER; Chinnakannu, K; Kim, SH; Menon, M; Murthy, S; Reddy, GP; Sivanandam, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sivanandam, A1
Murthy, S1
Chinnakannu, K1
Bai, VU1
Kim, SH1
Barrack, ER1
Menon, M1
Reddy, GP1

Other Studies

1 other study available for n-(6-aminohexyl)-1-naphthalenesulfonamide and Prostatic Neoplasms

ArticleYear
Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells.
    Journal of cellular physiology, 2011, Volume: 226, Issue:7

    Topics: Antineoplastic Agents; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin

2011